Note 4 - Inventory (Details Textual) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Dec. 31, 2025 |
|
| Inventory, Noncurrent | $ 26,346 | $ 15,689 |
| Inventory Valuation Reserves | 6,171 | $ 6,171 |
| Briumvi Ublituximab [Member] | ||
| Inventory, Noncurrent | 26,300 | |
| Inventory Write-down | 0 | |
| Inventory Valuation Reserves | $ 6,200 |
| X | ||||||||||
- Definition Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of valuation reserve for inventory. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|